Mobile tablet-based therapies following stroke: A systematic scoping review of administrative methods and patient experiences

<div><p>Background and purpose</p><p>Stroke survivors are often left with deficits requiring rehabilitation to recover function and yet, many are unable to access rehabilitative therapies. Mobile tablet-based therapies (MTBTs) may be a resource-efficient means of improving access to timely rehabilitation. It is unclear what MTBTs have been attempted following stroke, how they were administered, and how patients experienced the therapies. The review summarizes studies of MTBTs following stroke in terms of administrative methods and patient experiences to inform treatment feasibility.</p><p>Methods</p><p>Articles were eligible if they reported the results of an MTBT attempted with stroke participants. Six research databases were searched along with grey literature sources, trial registries, and article references. Intervention administration details and patient experiences were summarized.</p><p>Results</p><p>The search returned 903 articles of which 23 were eligible for inclusion. Most studies were small, observational, and enrolled chronic stroke patients. Interventions commonly targeted communication, cognition, or fine-motor skills. Therapies tended to be personalized based on patient deficits using commercially available applications. The complexity of therapy instructions, fine-motor requirements, and unreliability of internet or cellular connections were identified as common barriers to tablet-based care.</p><p>Conclusions</p><p>Stroke patients responded positively to MTBTs in both the inpatient and home settings. However, some support from therapists or caregivers may be required for patients to overcome barriers to care. Feasibility studies should continue to identify the administrative methods that minimize barriers to care and maximize patient adherence to prescribed therapy regiments.</p></div

Studies of mobile tablet-based therapies following stroke.

<p>Studies of mobile tablet-based therapies following stroke.</p

Characteristics of attempted mobile tablet-based therapies following stroke.

<p>Characteristics of attempted mobile tablet-based therapies following stroke.</p

Therapy dosages.

<p>Therapy dosages.</p

Participant mobile tablet-based therapy usage habits.

<p>Participant mobile tablet-based therapy usage habits.</p

Barriers to mobile tablet-based therapy following stroke.

<p>Barriers to mobile tablet-based therapy following stroke.</p

PRISMA flow diagram.

<p>PRISMA flow diagram.</p

Le Courrier

06 mai 18301830/05/06 (N126)

Appendix 1 -Supplemental material for RecoverNow: A patient perspective on the delivery of mobile tablet-based stroke rehabilitation in the acute care setting

<p>Supplemental material, Appendix 1 for RecoverNow: A patient perspective on the delivery of mobile tablet-based stroke rehabilitation in the acute care setting by Karen Mallet, Rany Shamloul, Michael Pugliese, Emma Power, Dale Corbett, Simon Hatcher, Michel Shamy, Grant Stotts, Lise Zakutney, Sean Dukelow and Dar Dowlatshahi in International Journal of Stroke</p

Additional file 1: of Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys

Additional details on the methods for the rapid review and evidence map. (PDF 174 kb